FutureChem Co.,Ltd (KOSDAQ:220100)

Market Cap	522.44B +10.7%
Revenue (ttm)	18.75B +19.2%
Net Income	-4.24B
EPS	-191.73
Shares Out	22.42M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	133,975
Average Volume	191,372
Open	23,450
Previous Close	23,200
Day's Range	22,800 - 23,550
52-Week Range	14,900 - 35,050
Beta	0.71
RSI	41.66
Earnings Date	Mar 16, 2026

About FutureChem Co.,Ltd

FutureChem Co.,Ltd engages in the research and development, production, and sale of chemicals, pharmaceuticals, and medical devices in South Korea and internationally. The company offers radioactive pharmaceuticals, including [18F]FDG for the treatment of general cancer diagnosis, PDvue for Parkinson's disease, Alzavue for Alzheimer's disease, and FLT for the lung cancer diagnosis. Its products in pipeline include [18F]FC303, [177Lu]FC705, and 225Ac for the treatment of prostate cancer; F-FMT for brain tumor diagnosis; FC-505 for the treatment ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 220100

Financial Performance

In 2024, FutureChem Co.,Ltd's revenue was 17.29 billion, an increase of 23.81% compared to the previous year's 13.97 billion. Losses were -9.42 billion, 40.4% more than in 2023.